Advanced search×

The James Lind Alliance: tackling research mismatches.

Sophie Petit-Zeman, Lester Firkins, and John W Scadding

Lancet 376(9742):667-9 (2010) PMID 20801389

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/S0140-6736(10)60712-X
Version: za2963e q8za2 q8zb3 q8zce q8zd6 q8ze9 q8zf2 q8zg9

Similar articles you may find interesting…

  1. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
    Emma Yue Zhang, Massimo Cristofanilli, and William S Hancock

    J Proteome Res (2013) PMID 23647160

    We selected three breast cancer cell lines (SKBR3, SUM149 and SUM190) with different oncogene expression levels involved in ERBB2 and EGFR signaling pathways as a model system for the evaluation of selective integration of subsets of transcriptomic and proteomic data. We assessed the oncogene status...
  2. Is Head and Neck Melanoma Different from Trunk and Extremity Melanomas with Respect to Sentinel Lymph Node Status and Clinical Outcome?
    Niloofar Fadaki, Rui Li, and Stanley P L Leong

    Ann Surg Oncol (2013) PMID 23649930

    Primary melanoma anatomic location is an independent predictor of SLN status and survival. Although HNM has a decreased SLN-positivity rate, it shows a significantly increased risk of recurrence and death as compared with other sites....
  3. Erratum to: Accelerated Gastric Emptying but No Carbohydrate Malabsorption 1 Year After Gastric Bypass Surgery (GBP).
    Gary Wang, Keesandra Agenor, and Blandine Laferrère

    Obes Surg (2013) PMID 23653400